Page last updated on April 11, 2024
ABVC BIOPHARMA, INC. reported their cybersecurity risk management and governance process in a yearly 10-K filed on 2024-03-13 17:14:37 EDT.
Filings
10-K filed on 2024-03-13
ABVC BIOPHARMA, INC. filed an 10-K at 2024-03-13 17:14:37 EDT
Accession Number: 0001213900-24-022235
Note: filing items unformatted. Drop us a note with the above URL to help us prioritize formatting it!
Item 1C. Cybersecurity.
ITEM 1C. CYBERSECURITY We plan to establish an appropriate confidentiality framework and adhere to relevant document management regulations. The Company and its employees are also required to sign confidentiality agreements for purposes including ensuring cybersecurity. As of the date of this report, we are not aware of any material risks from cybersecurity threats, that have materially affected or are reasonably likely to materially affect the Company, including our business strategy, results of operations, or financial condition.
Company Information
| Name | ABVC BIOPHARMA, INC. |
| CIK | 0001173313 |
| SIC Description | Pharmaceutical Preparations |
| Ticker | ABVC - Nasdaq |
| Website | |
| Category | Non-accelerated filer Smaller reporting company |
| Fiscal Year End | December 30 |